Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.43 - $5.9 $496 - $6,814
-1,155 Reduced 0.28%
404,581 $233,000
Q2 2022

Aug 12, 2022

SELL
$0.38 - $0.64 $600,880 - $1.01 Million
-1,581,265 Reduced 79.58%
405,736 $194,000
Q1 2022

May 13, 2022

SELL
$0.55 - $0.98 $51,865 - $92,414
-94,301 Reduced 4.53%
1,987,001 $1.33 Million
Q4 2021

Feb 08, 2022

SELL
$0.9 - $1.31 $322,371 - $469,230
-358,191 Reduced 14.68%
2,081,302 $2.05 Million
Q3 2021

Nov 15, 2021

BUY
$1.21 - $1.61 $80,703 - $107,382
66,697 Added 2.81%
2,439,493 $3.12 Million
Q2 2021

Aug 13, 2021

SELL
$1.6 - $2.02 $130,686 - $164,991
-81,679 Reduced 3.33%
2,372,796 $3.87 Million
Q1 2021

May 12, 2021

BUY
$1.86 - $2.87 $173,898 - $268,327
93,494 Added 3.96%
2,454,475 $4.86 Million
Q4 2020

Feb 11, 2021

SELL
$1.65 - $2.43 $17,488 - $25,755
-10,599 Reduced 0.45%
2,360,981 $4.89 Million
Q3 2020

Nov 16, 2020

SELL
$1.6 - $2.35 $138,230 - $203,025
-86,394 Reduced 3.51%
2,371,580 $4.06 Million
Q2 2020

Aug 14, 2020

BUY
$1.33 - $2.76 $2.68 Million - $5.56 Million
2,013,840 Added 453.43%
2,457,974 $5.7 Million
Q1 2020

May 14, 2020

BUY
$0.97 - $2.85 $46,351 - $136,187
47,785 Added 12.06%
444,134 $689,000
Q4 2019

Feb 14, 2020

BUY
$1.69 - $3.8 $13,132 - $29,529
7,771 Added 2.0%
396,349 $1.51 Million
Q3 2019

Nov 13, 2019

SELL
$0.61 - $2.21 $795,487 - $2.88 Million
-1,304,078 Reduced 77.04%
388,578 $715,000
Q2 2019

Aug 13, 2019

SELL
$0.51 - $0.86 $55,786 - $94,071
-109,386 Reduced 6.07%
1,692,656 $1.1 Million
Q1 2019

May 13, 2019

SELL
$0.51 - $0.82 $643 - $1,034
-1,262 Reduced 0.07%
1,802,042 $1.13 Million
Q4 2018

Feb 12, 2019

BUY
$0.48 - $1.1 $327 - $750
682 Added 0.04%
1,803,304 $871,000
Q3 2018

Nov 14, 2018

BUY
$1.06 - $1.69 $26,617 - $42,437
25,111 Added 1.41%
1,802,622 $1.98 Million
Q2 2018

Aug 14, 2018

BUY
$1.56 - $2.51 $254,244 - $409,072
162,977 Added 10.09%
1,777,511 $2.77 Million
Q1 2018

May 09, 2018

BUY
$0.91 - $2.24 $42,180 - $103,828
46,352 Added 2.96%
1,614,534 $3.46 Million
Q4 2017

Feb 14, 2018

SELL
$0.78 - $2.1 $8,172 - $22,001
-10,477 Reduced 0.66%
1,568,182 $1.45 Million
Q3 2017

Nov 13, 2017

BUY
$1.55 - $1.82 $2.45 Million - $2.87 Million
1,578,659
1,578,659 $2.79 Million

Others Institutions Holding DRRX

About DURECT CORP


  • Ticker DRRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 227,794,000
  • Market Cap $180M
  • Description
  • DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...
More about DRRX
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.